-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Vitiligo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Vitiligo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Vitiligo Drug Details: Afamelanotide (Scenesse) is an analog...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Acne Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Acne Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Acne Vulgaris Drug Details: Afamelanotide (Scenesse) is an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Acute Ischemic Stroke report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Acute Ischemic Stroke Drug Details: Afamelanotide (Scenesse)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bitopertin in Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bitopertin in Anemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bitopertin in Anemia Drug Details: Bitopertin is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bitopertin in Porphyria (Erythropoietic Protoporphyri)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bitopertin in Porphyria (Erythropoietic Protoporphyri) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bitopertin in Porphyria (Erythropoietic Protoporphyri) Drug Details: Bitopertin is under...
-
Product Insights
Aliansce Shopping Ctrs/ EPP Emp/ Iguatemi/ TDK Ent – Feira de Santana Shopping Center – Bahia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Aliansce Shopping Ctrs/ EPP Emp/ Iguatemi/ TDK Ent - Feira de Santana Shopping Center - Bahia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Company Profile
Clinuvel Pharmaceuticals Ltd – Company Profile
Clinuvel Pharmaceuticals Ltd (Clinuvel Pharmaceuticals) is a biopharmaceutical company which focuses on the development of drugs for the treatment of light related severe skin disorders. The company’s lead product candidate, Scenesse (afamelanotide) is a first-in-class drug targeting erythropoietic protoporphyria (EPP) and is approved in Europe, Australia and the US for treating adult EPP patients. Its other products under development includes CUV9900 and VLRX001 among others. Clinuvel Pharmaceuticals also focused on developing a pediatric formulation of Scenesse for EPP and OTC...
Add to Basket -
Company Profile
Aura Minerals Inc – Company Profile
Aura Minerals Inc (Aura) is a precious metals and mining company that carries out the development and operation of gold and base metal projects in South America, Central America, and North America. It focuses on the mining and production of copper, silver, and gold. The company owns 100% interest in the Aranzazu Copper Mine in Mexico and the San Andres Gold Mine in Honduras, the US. It holds 49% interests in EPP mines including Ernesto mine, Pau-a-Pique mine, Sao Francisco...
Add to Basket -
Product Insights
Sodium and Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Sodium and chloride dependent glycine transporter 1 is a protein encoded by the SLC6A9 gene. The Sodium and Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) pipeline drugs market research report provides comprehensive information on the Sodium and Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – afamelanotide acetate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry afamelanotide acetate Drug Details Afamelanotide (Scenesse) is an analog of the peptide hormone alpha-melanocyte...